We are live on ! Find out more
BIA

Biondo Investment Advisors Portfolio holdings

AUM $780M
1-Year Est. Return 21.03%
This Fund
S&P 500
This Quarter Est. Return
+18%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.37%
AUM
$433M
AUM Growth
+$42.1M
Cap. Flow
-$5.9M
Cap. Flow %
-1.36%
Top 10 Hldgs %
49.51%
Holding
92
New
6
Increased
40
Reduced
31
Closed
5

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$5.62M
2
ALGN icon
Align Technology
ALGN
+$5.05M
3
TWLO icon
Twilio
TWLO
+$2.5M
4
DD icon
DuPont de Nemours
DD
+$1.79M
5
LMT icon
Lockheed Martin
LMT
+$1.61M

Sector Composition

Rank Sector Weight
1 Healthcare 38.21%
2 Technology 16.83%
3 Financials 13.03%
4 Consumer Discretionary 7.41%
5 Communication Services 6.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIVB
26
DELISTED
SVB Financial Group
SIVB
$5.33M 1.23%
21,250
-1,590
-7% -$362K
BA icon
27
Boeing
BA
$185B
$5.33M 1.23%
16,257
+830
+5% +$294K
ABBV icon
28
AbbVie
ABBV
$433B
$5.25M 1.21%
59,354
-660
-1% -$54.8K
CRM icon
29
Salesforce
CRM
$152B
$5.23M 1.21%
32,172
-415
-1% -$65.1K
IOVA icon
30
Iovance Biotherapeutics
IOVA
$1.93B
$5.09M 1.18%
184,085
-750
-0.4% -$17.1K
MMM icon
31
3M
MMM
$91.4B
$4.78M 1.1%
32,135
+1,200
+4% +$168K
CHD icon
32
Church & Dwight Co
CHD
$23.7B
$4.77M 1.1%
67,625
-3,525
-5% -$250K
AMRN
33
Amarin Corp
AMRN
$297M
$4.58M 1.06%
10,681
+6,398
+149% +$2.43M
DUK icon
34
Duke Energy
DUK
$96.9B
$4.55M 1.05%
49,357
+1,264
+3% +$116K
XOM icon
35
ExxonMobil
XOM
$643B
$4.44M 1.03%
62,962
-470
-0.7% -$32.5K
BMY icon
36
Bristol-Myers Squibb
BMY
$134B
$4.29M 0.99%
66,888
+3,725
+6% +$213K
TEAM icon
37
Atlassian
TEAM
$26.3B
$4.16M 0.96%
34,595
-1,880
-5% -$229K
T icon
38
AT&T
T
$162B
$4.1M 0.95%
139,049
+6,256
+5% +$181K
GIS icon
39
General Mills
GIS
$19.2B
$4.05M 0.94%
75,699
+385
+0.5% +$20.3K
TFC icon
40
Truist Financial
TFC
$63.4B
$3.7M 0.85%
65,240
+8,560
+15% +$463K
AMZN icon
41
Amazon
AMZN
$3.06T
$3.56M 0.82%
38,480
+740
+2% +$65.5K
MO icon
42
Altria Group
MO
$114B
$3.39M 0.78%
67,874
+4,015
+6% +$189K
EW icon
43
Edwards Lifesciences
EW
$51.1B
$1.85M 0.43%
23,835
+7,755
+48% +$606K
XLV icon
44
State Street Health Care Select Sector SPDR ETF
XLV
$41.8B
$1.53M 0.35%
+15,025
New +$1.44M
GOOG icon
45
Alphabet (Google) Class C
GOOG
$4.56T
$1.46M 0.34%
21,820
-2,140
-9% -$138K
HDV
46
iShares Core High Dividend ETF
HDV
$14.8B
$1.42M 0.33%
72,460
+235
+0.3% +$4.48K
AMGN icon
47
Amgen
AMGN
$204B
$1.36M 0.31%
5,604
-5
-0.1% -$1.1K
RSP icon
48
Invesco S&P 500 Equal Weight ETF
RSP
$98.1B
$1.01M 0.23%
8,707
-7
-0.1% -$778
DOW icon
49
Dow Inc
DOW
$21.6B
$864K 0.2%
15,593
-1,030
-6% -$53.2K
BRK.B icon
50
Berkshire Hathaway Class B
BRK.B
$1.11T
$861K 0.2%
3,800

Similar funds

Biondo Investment Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Biondo Investment Advisors held 92 positions worth $433M, up 11% from $391M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Biondo Investment Advisors's Q4 2019 filing shows 6 new, 40 increased, 31 reduced and 5 closed positions. Its largest new stake was State Street Health Care Select Sector SPDR ETF: 15,025 shares worth $1.53M. The largest sale was Intel, an estimated $5.62M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 34% a quarter earlier, followed by Technology and Financials.

  • Biondo Investment Advisors's largest Q4 2019 buy was State Street Health Care Select Sector SPDR ETF: 15,025 shares worth $1.53M.
  • Biondo Investment Advisors added most to Vertex Pharmaceuticals in Q4 2019, an estimated $3.04M increase.
  • Biondo Investment Advisors's biggest Q4 2019 reduction was Align Technology, cutting an estimated $5.05M.
  • Biondo Investment Advisors fully exited Intel in Q4 2019, selling an estimated $5.62M.
  • Biondo Investment Advisors's ten largest holdings make up 50% of its $433M portfolio in Q4 2019.
  • Biondo Investment Advisors opened 6 new positions and closed 5 in Q4 2019.
  • Biondo Investment Advisors's portfolio value rose 11% quarter-over-quarter to $433M.

Based on Biondo Investment Advisors's 13F filing for Q4 2019, filed 6 Feb 2020.